Hydrogen Research Study
← Back to Research Library
Human clinical evidenceHuman Clinical Studyhydrogen-rich water

Hydrogen in Patients With Corticosteroid-Refractory/Dependent Chronic Graft-Versus-Host-Disease: A Single-Arm, Multicenter, Open-Label, Phase 2 Trial.

Liren Qian, Miao Liu, Jianliang Shen, Jian Cen, Defeng Zhao · Frontiers in immunology · 2020

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Molecular Hydrogen Overview
Evidence type Human clinical evidence
Publication type Human Clinical Study
Hydrogen method hydrogen-rich water

H2HUBB TAKEAWAY

In 24 patients, no significant toxicity was observed. This open-label study supports molecular hydrogen's therapeutic potential for the condition studied, while larger randomized, placebo-controlled studies are needed to confirm the finding.

What the Researchers Studied

24 patients

How the Study Was Conducted

Human clinical study

How Molecular Hydrogen Was Used

Patients received hydrogen-rich water 4ml/kg orally three times a day.

What the Researchers Found

No significant toxicity was observed.